Study directory

Schizophrenia studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
4306studies shown
Showing 3,445-3,456 of 4,306
Drug study icon
TerminatedEUCTR 2006-006940-69

Add-on treatment of mental illness with anti-viral medicine

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Sweden
Why is this study shown?

This study is directly about Schizophrenia.

Schizophrenia, BipolarityDrugA study involving a medication or substance.
Countries
Sweden
Sponsor
Lund University Hospital
Condition
Schizophrenia, Bipolarity
Drug study icon
CompletedEUCTR 2020-000439-32

An open-label, multi-center, extension study to evaluate the long-term safety, tolerability and preliminary efficacy of Evenamide as add-on treatment in patients with treatment-resistant schizophre...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Italy
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrug
Countries
Italy
Sponsor
NEWRON PHARMACEUTICALS SPA
Condition
Schizophrenia
Drug study icon
CompletedEUCTR 2013-000389-12

ANti-psychotic Drug REduction in primary care for Adults with Learning Disabilities (ANDREA-LD): A Randomised Double-blind Placebo Controlled Trial

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In United Kingdom
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrug
Countries
United Kingdom
Sponsor
Cardiff University
Condition
Schizophrenia
Drug study icon
CompletedEUCTR 2006-002682-40

Augmenting clozapine with sertindole - A double-blinded randomized placebo study (SERCLOZ)

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Denmark
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrug
Countries
Denmark
Sponsor
Aalborg Psychiatric Hospital, Research Unit
Condition
Schizophrenia
Biological study icon
TerminatedEUCTR 2013-000240-26

Cannabidiol as an add-on therapy in treatment-refractory psychotic disorders

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In United Kingdom
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaBiological
Countries
United Kingdom
Sponsor
King's College London [...] 1. King's College London 2. South London and Maudsley NHS Foundation Trust
Condition
Schizophrenia
Drug study icon
CompletedEUCTR 2009-010966-47

Clinical Effectiveness Of The Newer Antipsychotic Compounds Olanzapine, Quetiapine And Aripiprazole In Comparison With Low Dose Conventional Antipsychotics (Haloperidol And Flupentixol) In Patients...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Germany
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrug
Countries
Germany
Sponsor
Universität Bremen
Condition
Schizophrenia
Drug study icon
CompletedEUCTR 2007-006561-32

Effects of intranasal application of oxytocin on empathy and mentalising in patients with psychotic disorders and severe personality disorders

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Germany
Why is this study shown?

This study is directly about Schizophrenia.

Schizophrenia, Bipolarity, ...Drug
Countries
Germany
Sponsor
LWL University Hospital Bochum
Condition
Schizophrenia, Bipolarity, ...
Drug study icon
TerminatedEUCTR 2007-001520-12

Efficacy and distinctive effects of atypical antipsychotics on cognitive symptoms in dual diagnosis – A phase IIIb, randomized, open-labelled study to evaluate the cognitive effects of quetiapine X...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Portugal
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrug
Countries
Portugal
Sponsor
Unidade de Investigação em Saúde Mental e Psiquiatria do Centro Hospitalar Conde de Ferreira
Condition
Schizophrenia
Drug study icon
TerminatedEUCTR 2010-020467-21

Estudio en fase III multicéntrico aleatorizado, de 24 semanas, doble ciego, de grupos paralelos y controlado con placebo para evaluar la eficacia y la seguridad de RO4917838 en pacientes estables c...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Germany
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrug
Countries
Germany, Latvia, Lithuania, ...
Sponsor
F. Hoffmann-La Roche Ltd
Condition
Schizophrenia
Drug study icon
SuspendedEUCTR 2014-002765-30

European Long-acting Antipsychotics in Schizofrenia Trial EULAST

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Austria
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrug
Countries
Belgium, Austria, Czechia, ...
Sponsor
EGRIS
Condition
Schizophrenia
Drug study icon
CompletedEUCTR 2020-004374-22

HISTORI Home-based Intervention with Semaglutide Treatment Of Neuroleptica-Related Prediabetes The effect of Semaglutide on diabetes incidence and prevention in patients with in neuroleptica-relat...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Denmark
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrug
Countries
Denmark
Sponsor
Steno Diabetes Center Odense
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.